The evaluation of exposure to hepatitis A virus in HBsAg-positive persons: A multicentre study from Turkey

Basit Öğe Kaydı
dc.authorid0000-0003-0442-5981
dc.authorid0000-0002-5050-3832
dc.authorid0000-0001-6382-2229
dc.contributor.authorÇelen, Mustafa Kemal
dc.contributor.authorTürker, Kamuran
dc.contributor.authorÖztoprak, Nefise Çuvalcı
dc.contributor.authorŞener, Alper
dc.contributor.authorTuna, Nazan
dc.contributor.authorSırmatel, Fatma
dc.date.accessioned2021-06-23T18:55:38Z
dc.date.available2021-06-23T18:55:38Z
dc.date.issued2014
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractChronic hepatitis B is a major public health problem in our country. Hepatitis A vaccination in HBV carriers who did not encounter with Hepatitis A virus is also significant. We aimed to evaluate the rate of exposure to HAV in HBsAg-positive persons, and the distribution of seronegative individuals according to age groups. Medical records of 4793 patients from 14 centers who were positive for hepatitis B surface antigen (HBsAg). A total 3514 cases (73.3%) were male and 1279 (26.7) were female. The HBsAg positive patients who were previously tested for HAV IgG at the time of firstly admitted to a center. HBsAg positive patients who were previously not tested for HAV IgG were tested and these . patients were confirmed serologically for HAV. The distribution of cases according to age were determined. In this study, 4793 HBsAg-positive patients were evaluated. The ratio of testing of anti-HAV IgG was very low during the first visit (54.2%). Seronegativity was highest in the age group under 19 years of age (26.2%) followed by 20-25 age group (15.5%) and 26-29 age group (12.5%). Testing of HAV serology should not be ignored in especially HBsAg-positive young adults and seronegative young adults should be vaccinated.en_US
dc.identifier.endpage3068en_US
dc.identifier.issn0973-7510
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-84908208023en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage3063en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/4824
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84908208023&partnerID=40&md5=beb4cf4a92109c200ac0fdcf65f4f72a
dc.identifier.volume8en_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorSırmatel, Fatma
dc.language.isoenen_US
dc.publisherJournal of Pure and Applied Microbiologyen_US
dc.relation.ispartofJournal of Pure and Applied Microbiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnti-HAV IgGen_US
dc.subjectHBsAgen_US
dc.subjectHepatitis Aen_US
dc.titleThe evaluation of exposure to hepatitis A virus in HBsAg-positive persons: A multicentre study from Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu